|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn895163492 |
003 |
OCoLC |
005 |
20231120111904.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
141113s1967 enk o 001 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d OCLCF
|d YDXCP
|d EBLCP
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
066 |
|
|
|c (S
|
019 |
|
|
|a 896795930
|
020 |
|
|
|a 9781483226897
|q (electronic bk.)
|
020 |
|
|
|a 1483226891
|q (electronic bk.)
|
020 |
|
|
|z 9781483213460
|
035 |
|
|
|a (OCoLC)895163492
|z (OCoLC)896795930
|
050 |
|
4 |
|a RC271.C5
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/4061
|2 23
|
100 |
1 |
|
|a Greenwald, Edward S.,
|e author.
|
245 |
1 |
0 |
|a Cancer chemotherapy /
|c by Edward S. Greenwald.
|
264 |
|
1 |
|a London :
|b William Heinemann Medical Books, Ltd.,
|c 1967.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Medical outline series
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed November 13, 2014).
|
505 |
8 |
|
|6 880-01
|a A. MithramycinB. Combined Drug Therapies; C. Triple Therapy; D. Combined Radiotherapy and Drug Therapy; E. Regional Chemotherapy; F. Methylhydrazine Derivatives; CHAPTER IX. Hormone Therapy; A. Pharmacology; B. Estrogens; C. Androgens; D. Progestins; E. Corticosteroids and ACTH; F. Toxicity of Corticosteroids; G. Thyroid Hormone; CHAPTER X. Special Problems in Toxicity; A. Administration of Chemotherapeutic Agents to Pregnant Women; B. Uric Acid Nephropathy; C. Alopecia; CHAPTER XI. Chemotherapy of Specific Malignancies; A. Childhood Acute Leukemia; B. Adult Acute Leukemia.
|
505 |
8 |
|
|a C. Chronic Myelogenous LeukemiaD. Chronic Lymphocytic Leukemia; E. Lymphosarcoma; F. Reticulum Cell Sarcoma; G. Hodgkin's Disease; H. Wilm's Tumor; Other Embryonal Tumorsof Children; J. Multiple Myeloma; K. Breast Carcinoma; L. Adenocarcinoma of the Gastrointestinal Tract; M. Choriocarcinoma; N. Prostatic Carcinoma; O. Carcinoma of the Endometrium; P. Malignant Testicular Tumors; Q. Oat Cell Carcinoma of the Lung; R. Other Maligancies; INDEX.
|
520 |
|
|
|a Cancer Chemotherapy: Medical Outline Series discusses the benefits and risks of cancer chemotherapy. This book is composed of 11 chapters that cover the pharmacologic and therapeutic potentials of some chemotherapeutic agents. The opening chapter briefly considers the pharmacology of cancer chemotherapy. Considerable chapters are devoted to some cancer chemotherapeutic agents, including alkylating agents, methotrexate, 6-mercaptopurine, 5-fluorouracil, and Vinca rosea alkaloids. Each chapter examines the indications, dosage, toxicity, physiology, chemistry, and pharmacology of the agents. The.
|
650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
650 |
|
6 |
|a Cancer
|x Chimioth�erapie.
|0 (CaQQLa)201-0004691
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Cancer
|x Chemotherapy
|2 fast
|0 (OCoLC)fst00845327
|
776 |
0 |
8 |
|i Print version:
|a Greenwald, Edward S.
|t Cancer Chemotherapy.
|d Burlington : Elsevier Science, �2013
|z 9781483213460
|
830 |
|
0 |
|a Medical outline series.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9781483213460
|z Texto completo
|
880 |
0 |
|
|6 505-01/(S
|a Front Cover; ABOUT THE AUTHOR; Cancer Chemotherapy: Medical Outline Series; Copyright Page; Table of Contents; ACKNOWLEDGMENT; PREFACE; INTRODUCTION; Βι�bliography; CHAPTER I. Pharmacology of Cancer Chemotherapy; CHAPTER II. Alkylating Agents; A. Mechlorethamine; B. Chlorambucil; C. Busulfan; D. Triethylene Thiophosphoramide; E. Cyclophosphamide; F. Melphalan; CHAPTER III. Methotrexate; CHAPTER IV. 6-mercaptopurine; CHAPTER V. 5-fluorouracil; CHAPTER VI. Vinca Rosea Alkaloids; A. Vinblastine; B. Vincristine; CHAPTER VII. Actinomycin D; CHAPTER VIII. Miscellaneous Agents and Techniques.
|